Armando Bartolazzi

7PUBLICATIONS
26CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 17, 2024
The Unappreciated Value of a Cheap, 'Good Enough' Method of Detecting Thyroid Cancer.

Salvatore Sciacchitano, Massimo Rugge, Armando Bartolazzi

|Feb 05, 2024
Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape.

Giorgia Scafetta, Calogero D'Alessandria, Armando Bartolazzi

|Sep 11, 2021
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.

Stefano Di Giulio, Valeria Colicchia, Fabio Pastorino

|Apr 15, 2021
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.

Emiliano Maiani, Giacomo Milletti, Francesca Nazio

|Apr 03, 2019
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.

Carlo Capalbo, Giorgia Scafetta, Marco Filetti

|Sep 29, 2018
Galectins in Cancer and Translational Medicine: From Bench to Bedside.

Armando Bartolazzi

Pageof 2